{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:18:54Z","timestamp":1766711934296},"reference-count":2,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2131\/jts.41.459","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T18:14:43Z","timestamp":1468520083000},"page":"459-468","source":"Crossref","is-referenced-by-count":11,"title":["Acute biomarker panel changes associated with amphotericin B nephrotoxicity in female Sprague-Dawley rats"],"prefix":"10.2131","volume":"41","author":[{"given":"James Eric","family":"McDuffie","sequence":"first","affiliation":[{"name":"Preclinical Development and Safety, Janssen Research & Development, LLC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Lee","sequence":"additional","affiliation":[{"name":"Preclinical Development and Safety, Janssen Research & Development, LLC, USA"},{"name":"University of California Berkeley, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Ying","family":"Ma","sequence":"additional","affiliation":[{"name":"Preclinical Development and Safety, Janssen Research & Development, LLC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Chen","sequence":"additional","affiliation":[{"name":"Preclinical Development and Safety, Janssen Research & Development, LLC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Snook","sequence":"additional","affiliation":[{"name":"Preclinical Development and Safety, Janssen Research & Development, LLC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","unstructured":"EMA (2009): Final conclusions on the pilot joint EMEA\/FDA VXDS experience on qualification of nephrotoxicity biomarkers."},{"key":"2","unstructured":"FDA, U.S. (2014): Biomarker Letter of Support."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/4\/41_459\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T00:57:44Z","timestamp":1468630664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/41\/4\/41_459\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":2,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.41.459","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}